159891 医疗
已收盘 07-10 15:00:00
资讯
新帖
简况
广西推动优质AI医疗技术成果惠及东盟
中国新闻网 · 07-10 18:48
广西推动优质AI医疗技术成果惠及东盟
昂瑞微：主要应用于智能手机、无线外设、智能家居、健康医疗、智慧物流等领域
证券之星 · 07-10 15:33
昂瑞微：主要应用于智能手机、无线外设、智能家居、健康医疗、智慧物流等领域
普生医疗IPO：单品依赖遇集采寒冬 IPO前大股东密集套现离场
新浪证券 · 07-10 14:23
普生医疗IPO：单品依赖遇集采寒冬 IPO前大股东密集套现离场
港股异动 | 医渡科技(02158)涨超5% 参与共建北京重点实验室破解AI医疗黑盒难题 加速布局AI医疗生态
智通财经 · 07-10 11:40
港股异动 | 医渡科技(02158)涨超5% 参与共建北京重点实验室破解AI医疗黑盒难题 加速布局AI医疗生态
资金西进AI致医疗技术板块被低估，BMO高呼：历史性“黄金坑”显现，首推直觉外科(ISRG.US)等三大标的
智通财经 · 07-10 11:40
资金西进AI致医疗技术板块被低估，BMO高呼：历史性“黄金坑”显现，首推直觉外科(ISRG.US)等三大标的
理邦仪器获得实用新型专利授权：“医疗检测设备、毛细管适配器和进样针组件”
证券之星 · 07-10 03:31
理邦仪器获得实用新型专利授权：“医疗检测设备、毛细管适配器和进样针组件”
爱伦医疗（920050）披露2026年第二次临时股东会决议公告，7月9日股价下跌0.8%
证券之星 · 07-09 22:44
爱伦医疗（920050）披露2026年第二次临时股东会决议公告，7月9日股价下跌0.8%
普昂医疗（920069）披露关于注销部分募集资金专户的公告，7月9日股价下跌0.09%
证券之星 · 07-09 22:40
普昂医疗（920069）披露关于注销部分募集资金专户的公告，7月9日股价下跌0.09%
熵基科技：脑机技术聚焦教育、医疗、养老三大核心应用场景
证券之星 · 07-09 20:51
熵基科技：脑机技术聚焦教育、医疗、养老三大核心应用场景
7月9日石药创新涨7.47%，工银前沿医疗股票A基金重仓该股
证券之星 · 07-09 16:30
7月9日石药创新涨7.47%，工银前沿医疗股票A基金重仓该股
迈普医学（301033）披露收购易介医疗100%股权草案（修订稿），7月8日股价下跌4.27%
证券之星 · 07-08
迈普医学（301033）披露收购易介医疗100%股权草案（修订稿），7月8日股价下跌4.27%
GMR Solutions任命两位医疗行业领袖，董事会完成组建
环球市场播报 · 07-08
GMR Solutions任命两位医疗行业领袖，董事会完成组建
医渡科技（02158）共建北京重点实验室破解AI医疗黑盒难题，AI医疗闭环再落关键子
智通财经 · 07-08
医渡科技（02158）共建北京重点实验室破解AI医疗黑盒难题，AI医疗闭环再落关键子
Rubrik加入健康AI联盟，推动医疗领域负责任AI发展
环球市场播报 · 07-08
Rubrik加入健康AI联盟，推动医疗领域负责任AI发展
鹿得医疗（920278）披露前十大股东及前十大无限售条件股东情况公告，7月7日股价下跌2.25%
证券之星 · 07-07
鹿得医疗（920278）披露前十大股东及前十大无限售条件股东情况公告，7月7日股价下跌2.25%
锦好医疗（920925）披露2025年年度权益分派实施公告，7月7日股价下跌2.7%
证券之星 · 07-07
锦好医疗（920925）披露2025年年度权益分派实施公告，7月7日股价下跌2.7%
纽脉医疗冲刺科创板：年营收5801万，净亏1.29亿 奥博资本与淡马锡是股东
雷递 · 07-06
纽脉医疗冲刺科创板：年营收5801万，净亏1.29亿 奥博资本与淡马锡是股东
鹿得医疗（920278）披露回购股份报告书公告，7月6日股价下跌1.19%
证券之星 · 07-06
鹿得医疗（920278）披露回购股份报告书公告，7月6日股价下跌1.19%
纽脉医疗冲刺科创板：年营收5801万亏1亿 奥博资本与淡马锡是股东
雷递网 · 07-06
纽脉医疗冲刺科创板：年营收5801万亏1亿 奥博资本与淡马锡是股东
港股异动 | 德适-B(02526)早盘涨超13% 正式推出iMedLoop全球医疗影像数据平台 覆盖超90%临床场景
智通财经 · 07-06
港股异动 | 德适-B(02526)早盘涨超13% 正式推出iMedLoop全球医疗影像数据平台 覆盖超90%临床场景
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159891","market":"SZ","secType":"STK","nameCN":"医疗","latestPrice":0.372,"timestamp":1783667001000,"preClose":0.364,"halted":0,"volume":40152202,"delay":0,"changeRate":0.022,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.008,"latestTime":"07-10 15:00:00","open":0.364,"high":0.377,"low":0.36,"amount":14872000,"amplitude":0.0467,"askPrice":0.373,"askSize":7,"bidPrice":0.372,"bidSize":805,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":5,"adr":0,"adjPreClose":0.364,"symbolType":"fund","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":0.4,"lowLimit":0.328,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.525306,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159891","defaultTab":"news","newsList":[{"id":"2650706184","title":"广西推动优质AI医疗技术成果惠及东盟","url":"https://stock-news.laohu8.com/highlight/detail?id=2650706184","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650706184?lang=zh_cn&edition=full","pubTime":"2026-07-10 18:48","pubTimestamp":1783680480,"startTime":"0","endTime":"0","summary":"未来，优质AI医疗技术将成为广西深化与东盟医疗合作的重点。此外，广西还将依托南宁市数据领域国际合作试点，有序推进与东盟国家之间的医疗影像数据安全跨境流动，推动优质医疗大模型落地广西，面向东盟提供跨境远程诊断服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-07-10/doc-inihinfw3828737.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-10/doc-inihinfw3828737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","BK4581","VTHR","EEM","CHAT","BK4588","159891","BK4585","ARTY","BK4504","QTOC","AIPO","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650888841","title":"昂瑞微：主要应用于智能手机、无线外设、智能家居、健康医疗、智慧物流等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2650888841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650888841?lang=zh_cn&edition=full","pubTime":"2026-07-10 15:33","pubTimestamp":1783668801,"startTime":"0","endTime":"0","summary":"证券之星消息，昂瑞微(688790)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司产品除了在与卫星通信方面有应用，在其他方面还有哪些应用？昂瑞微回复：您好！感谢提问。公司核心产品线涵盖三大类，超四百款芯片，包括2G/3G/4G/5G全系列射频前端芯片、射频SoC芯片、模拟芯片。主要应用于智能手机、无线外设、智能家居、健康医疗、智慧物流等领域，积极拓展手机卫星通信、智能汽车、低空经济等新兴应用场景。感谢您的持续关注与支持！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000022254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","399996","165524"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650021629","title":"普生医疗IPO：单品依赖遇集采寒冬 IPO前大股东密集套现离场","url":"https://stock-news.laohu8.com/highlight/detail?id=2650021629","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650021629?lang=zh_cn&edition=full","pubTime":"2026-07-10 14:23","pubTimestamp":1783664580,"startTime":"0","endTime":"0","summary":"近日，珠海普生医疗科技股份有限公司科创板IPO申请获上交所受理，拟募资7.02亿元。作为全球一次性输尿管软镜出货量第一的国产医疗器械企业，普生医疗近三年营收复合增长率达46.3%，2025年营收突破5.38亿元，净利润近亿元，业绩表现颇为亮眼。 然而，亮丽财报的背后，多重风险正逐步显现，包括核心产品单一叠加集采政策冲击、研发投入持续走低与核心零部件外购依赖、超七成境外收入带来的经营不确定性、IPO前股东密集套现与治理架构调整等。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-07-10/doc-inihhzsf5188350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4127","FRHC","IPOS","KCE","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650909158","title":"港股异动 | 医渡科技(02158)涨超5% 参与共建北京重点实验室破解AI医疗黑盒难题 加速布局AI医疗生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2650909158","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650909158?lang=zh_cn&edition=full","pubTime":"2026-07-10 11:40","pubTimestamp":1783654858,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技涨超5%，截至发稿，涨4.58%，报5.48港元，成交额2617.21万港元。消息面上，近日，由北京大学第一医院牵头、医渡科技参与共建的“多模态智能诊疗系统研发与转化应用北京市重点实验室”正式揭牌，标志着一场旨在解决AI医疗“黑盒”难题、打通从数据治理到临床决策闭环的攻坚行动，已进入深水区。与此同时，医渡科技也在更广阔的生态层面加速布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465741.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","ARTY","BK4585","AIPO","KCAI","BK1617","159891","QTOC","BK1518","02158","VXUS","AGIX","BK4588","VTHR","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650909938","title":"资金西进AI致医疗技术板块被低估，BMO高呼：历史性“黄金坑”显现，首推直觉外科(ISRG.US)等三大标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2650909938","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650909938?lang=zh_cn&edition=full","pubTime":"2026-07-10 11:40","pubTimestamp":1783654824,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，BMO资本市场将直觉外科、Globus Medical和泰利福列为医疗技术领域中最具信心的股票。BMO的一项调查显示医院手术需求依然强劲，因此该分析师将该板块的疲软主要归咎于“资金流向和政策噪音，而非基本面”。乔普拉表示，他心中的“头号明星股”直觉外科目前的交易价格较其三年历史市盈率倍数折价约31%，尽管它在同行中拥有最强劲的基本面特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GLTR","ARTY","GOAU","GCmain","PALL","GDX","GLL","UGL","DUST","CHAT","IAUI","XME","PICK","DULL","159891","BAR","USG","SGOL","OUNZ","DZZ","DGP","BTGD","JDST","GDXY","BEGS","JNUG","159831","IAU","1OZmain","FAAR","IAUM","MGCmain","QOmain","SHNY","GBUG","FGDL","UYM","ISRG","CEF","VTHR","SGDM","AIPO","GLDM","AAAU","BMO","GDXD","GDXU","RING","PHYS","GDXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650487971","title":"理邦仪器获得实用新型专利授权：“医疗检测设备、毛细管适配器和进样针组件”","url":"https://stock-news.laohu8.com/highlight/detail?id=2650487971","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650487971?lang=zh_cn&edition=full","pubTime":"2026-07-10 03:31","pubTimestamp":1783625514,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示理邦仪器新获得一项实用新型专利授权，专利名为“医疗检测设备、毛细管适配器和进样针组件”，专利申请号为CN202520173839.9，授权日为2026年7月10日。今年以来理邦仪器新获得专利授权84个，较去年同期增加了95.35%。通过天眼查大数据分析，深圳市理邦精密仪器股份有限公司共对外投资了10家企业，参与招投标项目4283次；财产线索方面有商标信息291条，专利信息2059条，著作权信息696条；此外企业还拥有行政许可680个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000003271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300206","BK0251","BK0114","159891","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978931","title":"爱伦医疗（920050）披露2026年第二次临时股东会决议公告，7月9日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978931","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650978931?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:44","pubTimestamp":1783608252,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，爱伦医疗报收于25.92元，较前一交易日下跌0.8%，最新总市值为17.54亿元。公司于近日披露《2026年第二次临时股东会决议公告》。公告显示，江苏爱舍伦医疗科技集团股份有限公司于2026年7月8日召开2026年第二次临时股东会，会议由董事会召集，董事长张勇主持，采用现场与网络投票结合方式召开。出席会议股东共9人，代表有表决权股份总数的76.38%，会议合法合规。李碧诚被任命为董事，自2026年7月8日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650937978","title":"普昂医疗（920069）披露关于注销部分募集资金专户的公告，7月9日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650937978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650937978?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:40","pubTimestamp":1783608024,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，普昂医疗报收于34.0元，较前一交易日下跌0.09%，最新总市值为17.99亿元。该股当日开盘34.14元，最高34.25元，最低33.5元，成交额达1020.83万元，换手率为2.04%。近日，普昂（杭州）医疗科技股份有限公司发布《关于注销部分募集资金专户的公告》。本次注销未改变募投项目及资金用途，不影响项目正常实施。相关三方监管协议随之终止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650924230","title":"熵基科技：脑机技术聚焦教育、医疗、养老三大核心应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2650924230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650924230?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:51","pubTimestamp":1783601482,"startTime":"0","endTime":"0","summary":"证券之星消息，熵基科技(301330)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司研发的脑机接口产品，面向哪部分市场？是民用？养老？军用？烦请告知一下。熵基科技回复：尊敬的投资者，您好！公司脑机技术聚焦教育、医疗、养老三大核心应用场景，运用AI驱动的多模态数据融合技术，围绕分析诊断、检测辅助康复、治疗三大方向开展产品研发。脑机接口作为前沿技术领域，仍面临技术迭代、市场接受度、产业化进程等多方面不确定性。公司提请投资者注意投资风险。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900040472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","159891","301330"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650420739","title":"7月9日石药创新涨7.47%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650420739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650420739?lang=zh_cn&edition=full","pubTime":"2026-07-09 16:30","pubTimestamp":1783585858,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日石药创新涨7.47%，收盘报36.38元，换手率1.93%，成交量27.11万手，成交额9.66亿元。重仓石药创新的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共43家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。工银前沿医疗股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900028694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649994656","title":"迈普医学（301033）披露收购易介医疗100%股权草案（修订稿），7月8日股价下跌4.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649994656","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649994656?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:23","pubTimestamp":1783520595,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，迈普医学报收于55.1元，较前一交易日下跌4.27%，最新总市值为36.94亿元。近日，迈普医学披露《发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）（注册稿）（修订稿）》。公告显示，公司拟通过发行股份及支付现金的方式，向泽新医疗等10名交易对方购买其持有的广州易介医疗科技有限公司100%股权，并募集配套资金。本次交易构成关联交易，不构成重大资产重组，也不构成重组上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991715","title":"GMR Solutions任命两位医疗行业领袖，董事会完成组建","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991715","media":"环球市场播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649991715?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:17","pubTimestamp":1783520220,"startTime":"0","endTime":"0","summary":"全美最大的急救医疗服务提供商GMR Solutions宣布，任命Amar Desai博士和Ellen Zane为董事会成员，自2026年7月1日起生效。Desai将担任董事会提名、公司治理及合规委员会委员。 此次任命标志着GMR董事会正式组建完成。 GMR Solutions是全美最大的急救医疗服务提供商，业务覆盖约1400个县，拥有约3.4万名员工，每年服务约550万名患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-08/doc-inihceiw4843023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891","GMRS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649529889","title":"医渡科技（02158）共建北京重点实验室破解AI医疗黑盒难题，AI医疗闭环再落关键子","url":"https://stock-news.laohu8.com/highlight/detail?id=2649529889","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649529889?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:41","pubTimestamp":1783482094,"startTime":"0","endTime":"0","summary":"近日，由北京大学第一医院牵头、医渡科技参与共建的“多模态智能诊疗系统研发与转化应用北京市重点实验室”正式揭牌，标志着一场旨在解决AI医疗“黑盒”难题、打通从数据治理到临床决策闭环的攻坚行动，已进入深水区。“多模态智能诊疗”重点实验室的成立，是医渡科技深度融入北京“人工智能+医疗”战略的缩影。当“可循证”成为智能体标配，AI才真正有资格进入生命攸关的决策环。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1518","02158","BK1617","BK1189","159891","CHAT","VTHR","ARTY","QTOC","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649932922","title":"Rubrik加入健康AI联盟，推动医疗领域负责任AI发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2649932922","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649932922?lang=zh_cn&edition=full","pubTime":"2026-07-08 03:07","pubTimestamp":1783451220,"startTime":"0","endTime":"0","summary":"数据安全与AI运营公司Rubrik宣布加入健康AI联盟，将致力于与联盟成员围绕网络弹性与AI治理开展合作，共同推动AI在医疗领域的负责任开发、部署与应用。 Rubrik医疗首席技术官Josh Howell表示，AI改变医疗的潜力巨大，但负责任地扩展需要严格的防护措施、及时的运营恢复能力，以及全面监控、治理和回溯AI行为的能力。 CHAI首席执行官Brian Anderson对Rubrik的加入表示欢迎，并期待各方合作在信任、安全和可靠的基础上释放AI的潜在益处。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-08/doc-inifzmys5027414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RBRK","LU2286300806.USD","BK4613","ARTY","150219","QTOC","PSWD","CHAT","SPAM","AGIX","159891","BK4097","VTHR","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649936946","title":"鹿得医疗（920278）披露前十大股东及前十大无限售条件股东情况公告，7月7日股价下跌2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649936946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649936946?lang=zh_cn&edition=full","pubTime":"2026-07-07 23:00","pubTimestamp":1783436441,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘，鹿得医疗报收于5.66元，较前一交易日下跌2.25%，最新总市值为9.88亿元。该股当日开盘5.78元，最高5.84元，最低5.66元，成交额达572.8万元，换手率为1.35%。公司于近日披露《前十大股东和前十大无限售条件股东情况公告》。公告显示，截至2026年7月2日，项友亮持有公司股份比例为22.42%，为第一大股东；前十大无限售条件股东中，祝增凯持股比例为3.08%，居首位。该股东信息系用于公司回购股份相关信息披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700042260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649936912","title":"锦好医疗（920925）披露2025年年度权益分派实施公告，7月7日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649936912","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649936912?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:59","pubTimestamp":1783436351,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘，锦好医疗报收于10.46元，较前一交易日下跌2.7%，最新总市值为10.31亿元。公司于近日披露《2025年年度权益分派实施公告》。公告显示，惠州市锦好医疗科技股份有限公司2025年年度权益分派方案已获股东会审议通过，以股权登记日应分配股数97,729,643股为基数，向股东每10股派发现金红利0.500000元，共计派发现金红利4,886,482.15元。公司将对限制性股票激励计划的授予价格进行相应调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700042253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649760214","title":"纽脉医疗冲刺科创板：年营收5801万，净亏1.29亿 奥博资本与淡马锡是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2649760214","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649760214?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:15","pubTimestamp":1783332900,"startTime":"0","endTime":"0","summary":"时隔近5年之后，在其他企业纷纷转战港股之际，纽脉医疗反而放弃港股，选择冲刺科创板。年营收5801万，净亏1.29亿纽脉医疗是一家专注于介入式人工心脏瓣膜、介入式心室辅助系统的创新医疗器械公司。招股书显示，纽脉医疗2023年、2024年、2025年营收分别为652万、2806万、5800.8万元；净亏损分别为3亿、1.63亿、1.29亿元；扣非后净利分别为-2.97亿、-1.58亿、-1.18亿元。虞奇峰合计控制38.5279%股份的表决权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661677579&idx=6&sn=dd96cc384d9287477b57a220234f04d5&chksm=bdc777f98ab0feefbcf301f77da40c3c3f61011fb8e5316c8020e7f5284c6288be6bd0a32c05#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649582628","title":"鹿得医疗（920278）披露回购股份报告书公告，7月6日股价下跌1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649582628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649582628?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:47","pubTimestamp":1783331259,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，鹿得医疗报收于5.79元，较前一交易日下跌1.19%，最新总市值为10.1亿元。该股当日开盘5.85元，最高6.07元，最低5.75元，成交额达1513.54万元，换手率为3.46%。近日，鹿得医疗披露《回购股份报告书公告》。公告显示，公司拟以自有资金通过竞价方式回购公司股份，用于实施员工持股计划或股权激励。回购期限为董事会审议通过之日起不超过12个月。公司已开立回购专用证券账户，相关主体在回购期间暂无减持计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600025542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649452186","title":"纽脉医疗冲刺科创板：年营收5801万亏1亿 奥博资本与淡马锡是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2649452186","media":"雷递网","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649452186?lang=zh_cn&edition=full","pubTime":"2026-07-06 13:47","pubTimestamp":1783316852,"startTime":"0","endTime":"0","summary":"上海纽脉医疗科技股份有限公司（简称：“纽脉医疗”）日前递交招股书，准备在科创板上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260706/6391894244839085311995005.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260706/6391894244839085311995005.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34286/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["159891","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649761272","title":"港股异动 | 德适-B(02526)早盘涨超13% 正式推出iMedLoop全球医疗影像数据平台 覆盖超90%临床场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2649761272","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649761272?lang=zh_cn&edition=full","pubTime":"2026-07-06 09:34","pubTimestamp":1783301694,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B早盘涨超13% ，截至发稿，涨8.58%，报336.6港元，成交额247.56万港元。消息面上，7月4日，德适-B“医疗AI全域生态创新研讨暨iMedLoop全球医疗影像数据平台发布会”在北京举办，正式发布最新产品——iMedLoop全球医疗影像数据平台。在模型训练层面，德适已构建iMedImage医学影像基座模型，是全球首个千亿级参数跨模态医学影像大模型，支持19种影像模态、覆盖超90%临床场景，突破传统单一模态技术局限，可作为专病专科模型开发的底层引擎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","BK1100","159891","KCAI","BK4588","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783827396406,"stockEarnings":[{"period":"1week","weight":-0.0159},{"period":"1month","weight":-0.0027},{"period":"3month","weight":-0.1268},{"period":"6month","weight":-0.2085},{"period":"1year","weight":-0.1349},{"period":"ytd","weight":-0.1308}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0025},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医疗,159891,医疗股票,医疗股票老虎,医疗股票老虎国际,医疗行情,医疗股票行情,医疗股价,医疗股市,医疗股票价格,医疗股票交易,医疗股票购买,医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医疗(159891)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医疗(159891)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}